1.Non-Proliferative Breast Disease. Non-Proliferative Breast

1. Non-proliferative Breast Disease Non-proliferative breast disease, the most common lesion, is associated with small increased risk or no effect (relative risk 0.9-1.6) (e.g., fibroadenoma, cysts). 2. Proliferative Breast Disease without Atypia Women with proliferative breast disease without atypia had about 1.5 to 1.9 fold increased risk (e.g., adenosis, intraductal papilloma). 3. Atypical Hyperplasia Atypical hyperplasia produced about a 3 to 5 fold higher risk of breast cancer. Pathology of Breast Cancer Breast cancers can be classified by different schemes. Each of these aspects influences treatment response and prognosis. Description of a breast cancer would optimally include all of these classification aspects, as well as other†¦show more content†¦Patients with a high score benefit from radiotherapy after excision, whereas those of low grade, whose tumor is completely excised, need no further treatment. (Williams, et al., 2013) Surgical Treatment Options of DCIS a. Mastectomy for Patients with DCIS Mastectomy is by far the most effective treatment available for DCIS if the goal is simply to prevent local recurrence. Most mastectomy series reveal local recurrence rates of approximately 1% with mortality rates close to zero. Mastectomy is an aggressive form of treatment for patients with DCIS. It clearly provides a local recurrence benefit but only an indemonstrable and theoretical survival benefit. It is, therefore, often difficult to justify mastectomy, particularly for otherwise healthy women with screen-detected DCIS, during an era of increasing utilization of breast conservation for invasive breast carcinoma. Mastectomy is indicated in cases of true multicentricity (multi-quadrant disease) and when a unicentric DCIS lesion is too extensive to excise with clear margins and an acceptable cosmetic result. Genetic positivity to one or more of the breast cancer associated genes (BRCA1, BRCA2) is not an absolute contraindication to breast preservation, but many patients who are genetically positive and who develop DCIS seriously consider bilateral mastectomy. (Kuerer, 2010) b. Breast Conservation for PatientsShow MoreRelatedSymptoms And Treatment Of A Diabetic Patient With Cancer Patients913 Words   |  4 PagesAccording to American Cancer society individuals with stage 1 CRC have a 90% five year survival rate with only 12% five-year survival rate with individual with stage 4 CRC. Stage 4 is defined as cancer that has metastasized to distant organs that many include the liver. Current treatment for CRC involves the use of surgery, chemotherapy as well as radiation. Generally surgery is considered first line treatment for CRC in which the affected portion of the colon is removed. Since hyperglycemia inRead MoreBreast Cancer : A Complex And Heterogeneous Disease Caused By Genetic Mutations782 Words   |  4 PagesBreast cancer is a complex and heterogeneous disease caused by both genetic and non-genetic risk factors. These factors include, mutations in breast cancer-associated genes 1 and 2 (BRCA1 and BRCA2) [1]; loss or aberrant expression of the est rogen receptor (ER) [2]; human epidermal growth factor receptor (HER2) overexpression [3] ; lack of ER, progesterone receptor (PR), and epidermal growth factor receptor (EGFR) expression[4] ; high levels of receptor for the insulin-like growth factor receptorRead MoreShort Non Coding Rnas Play : The Rna And Represses The Translation Process By Controlling Gene Expression1559 Words   |  7 PagesAbstract: MicroRNAs are short non-coding RNAs play main role in human diseases; it deregulates the RNA and represses the translation process by controlling gene expression. Some deregulated miRNAs express deferentially such as mir-125b, mir-145, mir-155, and mir-21 leads for partition between cancer and normal tissues. miRNAs expression with particular cancer biopathologic features in breast, such as tumor stage, estrogen and progesterone receptor expression, vascular invasion, or proliferation indexRead MorePssc Research Paper780 Words   |  4 Pagesand Generation of Human Cardiomyocytes from iPSCs Slide 1-23 1500 words Advances in Application of iPSC-derived Cardiomyocytes for Future Medicine -Modeling Inherited cardiomyopathy with human iPSC-derived cardiomyocytes The advent of iPS cell technology and improvements in protocols for cardiomyocytes differentiation open the door to using iPSC-CMs platform for disease modeling and toxicological assays in various cardiovascular diseases. To data, one of the most successful area in research applicationRead MoreAnalysis Of Nigella Sativa And Its Effects On The Treatment Of Cancer3007 Words   |  13 Pageseffects that help explain its medicinal properties. More recently, Nigella sativa and its major active compound, thymoquinone, have become an area of interest in the treatment of cancer. As one of the leading causes of death, cancer is a dreadful disease with no known cure and treatments with high toxicity and expense. In an effort to find drugs with lower levels of toxicity, scientists have turned to naturally occurring compounds, and Nigella sativa has shown great promise. Numerous studies haveRead MoreDevelopment Of The Mammary Gland9524 Words   |  39 PagesIntroduction 1. Normal mammary gland 1.1 normal mammary gland anatomies The normal breast sits on the chest muscle, consisting mainly of adipose tissue, also known as mammary fat pad. The mature mammary gland is composed of 15-20 lobes, which are each composed of smaller structure called lobules. Tiny Lactiferous ducts connect lobules to each other. (Fig. 1b) (Schneider and Bocker). A typical structure of duct is composed of a hollow lumen, enclosed by a layer of epithelial luminal cells that produceRead MoreNew Therapeutic Strategies For Ovarian Cancer1902 Words   |  8 Pagescancer is the fifth leading cause of cancer-related deaths in females in the United States. It is anticipated that there will be about 22,280 new cases and 14,240 deaths due to ovarian cancer in 2016 [70]. Most patients present with advanced stage disease, contributing to the high death rate. Generally, these patients are treated with surgical resection followed by platinum-based chemotherapy [71]. A significant problem faced in treating these patients is the high rate of recurre nce associated withRead MoreHuman Kallikrein Related Peptidases ( Klks )8953 Words   |  36 PagesCancer is the second leading cause of death with 14 million new cases and 8.2 million cancer-related deaths worldwide in 2012. Despite the progress made in cancer therapies, neoplastic diseases are still a major therapeutic challenge notably because of intra- and inter-malignant tumor heterogeneity and adaptation/escape of malignant cells to/from treatment. New targeted therapies need to be developed to improve our medical arsenal and counter-act cancer progression. Human kallikrein-related peptidasesRead MoreEssay On 20 Years Of Advancement In Healthcare Science1109 Words   |  5 PagesHealthcare Science and Potential Future Developments Over the last twenty years there have been numerous important advances throughout healthcare science. These have allowed for improved diagnoses and more effective treatments lowering the prevalence of diseases. The first significant advancement discussed in this essay is The Human Genome Project (HGP), an international collaborative research program whose goal was to sequence and map all of the genes (known as the genome) contained within humans. ThisRead MoreOvarian Cancer Case Study837 Words   |  4 Pagesimmunohistochemistry in 37 samples, DICER showed a significant upregulation in high-grade serous ovarian cancer. High DICER expression was associated with absence of lymph node metastasis and a low proliferation index. DICER expression did not correlate with disease free or overall survival (16). The authors did not comment on DROSHA expression by immunohistochemistry and, thus, did not comment on the association of DROSHA with clinical factors. Additionally, only high-grade serous EOC tumor samples were examined